HEMATOLOGICAL FINDINGS IN COVID-19 AND INSIGHTS TO STEM CELL THERAPY

Objective: As the COVID-19 was spreading to all countries, its manifestations were identifying gradually, which were related to several organs. COVID-19 is associated with distinct hematological changes, increased serum inflammatory markers, and coagulopathy. Methodology: Most of the known COVID 19...

Description complète

Enregistré dans:
Détails bibliographiques
Auteur principal: Ghada ELGohary
Format: article
Langue:EN
Publié: Elsevier 2021
Sujets:
Accès en ligne:https://doaj.org/article/418d89f0e44d45418c6896c63db05dc7
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
Description
Résumé:Objective: As the COVID-19 was spreading to all countries, its manifestations were identifying gradually, which were related to several organs. COVID-19 is associated with distinct hematological changes, increased serum inflammatory markers, and coagulopathy. Methodology: Most of the known COVID 19 complications are related to the patients’ prognosis and mortality, particularly in those with severe disease, the issue which attract the scientists and the medical physicians all over the world to find the proper treatment for such monter, we discussed the associations between COVID-19 clinical features and complications, and secondly, its hematological findings and coagulopathy are investigated. Conclusions: Such associations not only may shed light on our prognostic view of patients with COVID-19 but also will entail significant therapeutic implications. One of its key implications is to utilize the mesenchymal stem cells (MSCs) to treat patients with COVID-19. Herein, this kind of novel therapy has been discussed, as well with its cons and pros points